Europe Medical Cannabis Market Trends, Size, Segment and Growth by Forecast to 2030

 The Europe medical cannabis market is projected to grow from US$ 492.1 million in 2021 to US$ 13,801.0 million by 2028, registering an impressive CAGR of 61.1% from 2022 to 2028. This remarkable growth is primarily driven by increasing research into the medicinal applications of cannabis and growing government support and funding. However, the continued illegal use of cannabis as a recreational drug may pose challenges to market expansion.

While a significant number of European countries are adopting medical cannabis legislation, it remains uncommon for governments to actively encourage healthcare professionals to gain formal education on cannabis-based therapies. A notable exception occurred in 2016 when cannabis experts were invited to Macedonia to train local healthcare providers on the clinical use of cannabis. The initiative, held in Skopje, was supported and financed by the Macedonian Ministry of Health.

๐Ÿ“šDownload Full PDF Sample Copy of Market Report @
https://www.businessmarketinsights.com/sample/TIPRE00018766

Macedonia presents unique opportunities in the medical cannabis landscape, especially as the country’s healthcare system undergoes modernization. Local specialists are now authorized to prescribe medical cannabis, marking a major milestone. In response, Macedonian cannabis advocates have collaborated with local governments to establish medical cannabis training programs aimed at supporting doctors and enhancing patient care.

The momentum of Macedonia’s medical cannabis movement is accelerating, accompanied by a significant shift in public perception toward acceptance of cannabis as a legitimate medical treatment. This regional transformation underscores the urgent need for the European Commission and EU Member States to address the regulatory, financial, and cultural obstacles that continue to hinder cannabis research—and to expand funding for scientific studies in this field.

Europe Medical Cannabis Strategic Insights

Strategic insights for the Europe Medical Cannabis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Market leaders and key company profiles
  Organigram Holdings Inc

  Aurora Cannabis Inc

  Cannabis Science, Inc

  Canopy Growth Corporation

  Medical Marijuana Inc

  VIVO Cannabis Inc

  Tikun Olam

  Tilray

  The Cronos Group

  Canvory

Europe Medical Cannabis Regional Insights

The geographic scope of the Europe Medical Cannabis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Similarly, the government is granting funds to accelerate R&D activities on cannabis use for COVID-19. For instance, in September 2020, EXMceuticals Inc. announced receiving funds for focusing on R&D for landmark COVID-19 activities. The European Union and the Portuguese government have allocated funds of ~US$ 353,000 (EUR 302,000) to support the company’s BioBlockCOVID project, which aims to create functional, natural, and innovative biocide formulations targeting specific molecules that makeup COVID-19. It is expected that the funds would enhance the research activities and help in innovating newer techniques. Thus, due to the above advancements, the medical cannabis market is expected to grow at a rapid pace during the forecast period.

Country Analysis

The prescription of medical cannabis for medical use was legalized in Germany in March 2017. There are different types of medicinal cannabis products found in Germany. German pharmacies are selling more medicinal cannabis to patients. According to Germany’s Federal Ministry of Health, sales have increased from 33.8 kg in the first six months of 2015 to 61.8 kg in the first six months of 2016. In addition, clinical studies with medical cannabis or single cannabinoids in different diseases are increasing. Sativex was licensed in Germany in 2011 as an add-on therapy for moderate-to-severe multiple sclerosis (MS) treatment-resistant spasticity symptoms. In Germany, Sativex clinical trials have proved that Sativex is a cost-effective treatment option for patients with MS spasticity.  

Additionally, due to rising medical applications of medical cannabis, in July 2018, Germany’s Federal Institute for Drugs and Medical Devices (BfArM) permitted the growth of 10,400 kg of medical cannabis in Germany over the next four years. Owing to increased cultivation of medical cannabis and growing government support for medical cannabis cultivation drive the growth of the medical cannabis market.         

The Centers for Disease Control and Prevention (CDC), National Library of Medicine, Prohibition Partners, State Agency for Medical Cannabis (SAKL), and Worldometer are among the primary and secondary sources referred to while preparing the report on the Europe medical cannabis market.



Can you see this our reports


Europe Halal Cosmetics Market – https://postyourarticle.com/europe-halal-cosmetics-market-trends-size-segment-and-growth-by-forecast-to-2030-3/


Europe Stevia Market – https://businessmarketins02.blogspot.com/2025/05/europe-stevia-market-trends-size.html


North America Functional Beverages Market – https://sites.google.com/view/businessmarketinsights233/home


North America Biodegradable Plastics Market – https://github.com/businessmarketinsights985/business-market-insights/issues/86


Europe Dental Market – https://www.linkedin.com/feed/update/urn:li:activity:7329122009718636569?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFoU1YcBnRwRNJ26KRFoU-JXA3i-VZNmbCk


About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Dรฉfense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications


Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights

Comments

Popular posts from this blog

North America Animal Feed Market Trends, Size, Segment and Growth by Forecast to 2030

North America Meat Extract Market Trends, Size, Segment and Growth by Forecast to 2030

Benelux Heavy Construction Equipment Market Trends, Size, Segment and Growth by Forecast to 2030